¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01
±³À°ÀÏÀÚ : 2024-06-01
±³À°Àå¼Ò : ¼­¿ï ½ºÀ§½º±×·£µåÈ£ÅÚ

±³À°ÁÖÁ¦ : 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À°

ÁÖÃÖ±â°ü : ´ëÇѳ»°úÇÐȸ
¿¬¶ôó : 02-793-4364  

À̸ÞÀÏ : kaim4364@kaim.or.kr

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 1500¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 27 ½Ã°£ 0ºÐ

¼¼ºÎ¼ö°­·á : 80,000¿ø  

ºñ°í "³»°úȸ¿ø: »çÀüµî·Ï - 50,000¿ø / ´çÀϵî·Ï 60,000¿ø

ºñȸ¿ø(Ÿ°ú): »çÀüµî·Ï - 70,000¿ø / ´çÀϵî·Ï 80,000¿ø" 


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 13:30~13:55 Diagnosis and Management of Functional Dyspepsia ¿ÀÁ¤È¯(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 13:55~14:15 Diagnosis and Management of Eosinophilic Esophagitis Á¤±â¿í(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 14:15~14:40 Diagnosis and Treatment of Functional Constipation À±Áø¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 14:40~15:00 Recent Update on the Management of Inflammatory Bowel Disease ¼ÛÀº¹Ì(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 15:30~15:55 Recent Update on the Management of Steatotic Liver Disease ÀÌÀç½Â(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 15:55~16:15 Simplified Treatment for Hepatitis C Virus ÀÌÇѾÆ(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 16:15~16:40 Diagnosis and Management of Gallstone Diseases ·ù±âÇö(°Ç¾çÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 16:40~17:00 Recent Update on the Management of Biliary Tract Cancer ÃÖÁøÈ£(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 08:30~09:00 Current Guidelines for Heart Failure À±Á¾Âù(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 09:00~09:30 Current Guidelines for Hypertension         ÀÌÂùÁÖ (¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 09:30~10:00 Current Guidelines for Acute Coronary Syndrome À±ÇõÁØ(°è¸íÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 10:30~11:00 Update on Atrial Fibrillation °íÁ¡¼®(¿ø±¤ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 11:00~11:30 Update on Valvular Heart Disease ¼ÕÁ¤¿ì(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 11:30~12:00 Update on Bradyarrhythmia ¹ÚÁ¾¼º(µ¿¾ÆÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 13:30~14:00 FeNO/IOS ÀÌ Çö( ÇѾçÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 14:00~14:30 Transbronchial Biopsy for Peripheral Lung Lesions ¾öÁß¼·(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 14:30~15:00 Thoracic Ultrasound ¾ÈÅÂÁØ(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 15:30~16:00 Update on Inhaler Treatment for Chronic Airway Disease ½Å¼±Çý (°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 16:00~16:30 Update of PPF: Diagnosis and Treatment ÀÌÀçÇÏ(ÀÎÁ¦ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 16:30~17:00 Immunotherapy for Non-Small Cell Lung Cancer ±è¹ÌÇö(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 08:30~09:00 Diagnosis and Management of Diabetes; Lesson from Recent Guidelines °­½Å¾Ö(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 09:00~09:30 Novel Role of Mineralocorticoid Receptor Inhibition in the Treatment of Diabetic Kidney Disease ±è³­Èñ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 09:30~10:00 CGM and Automated Insulin Delivery Áø»ó¸¸(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 10:30~11:00 Discrimination of Secondary Osteoporosis À̽ÂÈÆ(¿ï»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 11:00~11:30 Treatment Guidelines for Hypoparathyroidism ¾È¼ºÈñ(ÀÎÇÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 5°­ÀÇ½Ç 11:30~12:00 Recent Update for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis ¹Ú¼Ò¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 13:30~14:00 Basic Overview of Electrolytes and Acid-Base Balance in Renal Physiology ÀåÇý·Ã(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 14:00~14:30 Sodium and Water Balance Disorder ¹®ÁÖ¿µ(°æÈñÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 14:30~15:00 Potassium Disorder in Hospitalized and Critically ill Patients °íÀº½Ç(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 15:30~16:00 High Anion-Gap Metabolic Acidosis ±Ç¼ø±æ(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 16:00~16:30 Acid-Base Disorders in Hospitalized and Critically ill Patients °­¼®ÈÖ(¿µ³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 16:30~17:00 Metabolic Acidosis in Patients with CKD ±èÀÏ¿µ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 08:30~09:00 Recent Advances in AML ¹Ú¿ë(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 09:00~09:30 Recent Advances in MPN È«ÁؽÄ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 09:30~10:00 Recent Advances in MM ±è°æÇÏ(¼øõÇâÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 10:30~11:00 Biomarker in solid tumor using liquid biopsy ±è¸í½Å(°¡Å縯ÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 11:00~11:30 Application of ct DAN in clinical practice Â÷¿ëÁØ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 06¿ù 01ÀÏ 1°­ÀÇ½Ç 11:30~12:00 Different signal of PD-L1 in solid tumor as biomarker Á¤¹Î±Ô(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 13:30~14:00 Current Update on Diagnostic approach of Infectious Diseases ¹Ú¼º±Õ(°è¸íÀÇ´ë Áø´Ü°Ë»çÀÇÇаú)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 14:00~14:30 How to use Recently Approved Broad Spectrum Beta-lactams? À±¿µ°æ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 14:30~15:00 Long-awaited novel antibiotics still not introduced in Korea ÀÌÈ¿Áø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 15:30~16:00 Adult Immunization Policy in Korea ÇãÁß¿¬(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 16:00~16:30 Guidelines on the Diagnosis and Treatment of Diabetes-related Foot Infections ÃÖÀç±â(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 2°­ÀÇ½Ç 16:30~17:00 Management of Endocarditis:  2023 ESC Guidelines for the Management of Endocarditis Á¶µ¿È£(¸íÁöº´¿ø)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 08:30~09:15 Implementing Anti-Inflammatory Reliever Strategies in Mild to Moderate Asthma ÀÌÁöÈ£(¿¬¼¼¿øÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 09:15~10:00 Management and New Targeted Therapies in Chronic Cough ±è¹ÎÇý(ÀÌÈ­ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 10:30~11:00 Drug Allergy Delabeling in Clinical Practice ±è¼º·Ä(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 11:00~11:30 Advances in Mechanisms and Management  of Delayed Drug Hypersensitivity Reaction ½É´Ù¿î(Àü³²ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 3°­ÀÇ½Ç 11:30~12:00 Current and Future Management of Chronic Spontaneous Urticaria and Chronic Inducible Urticaria ÀÌÁöÇâ(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 08:30~09:00 Update of Osteoarthritis & Osteoporosis ±èÇö¾Æ(¾ÆÁÖÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 09:00~09:30 Novel Treatments in Inflammatory Myopathy ¹®¼öÁø(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 09:30~10:00 Update of Rheumatoid Arthritis õÀ±È«(°æ»óÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 10:30~11:00 Corticosteroid-Free Adalimumab-Cyclophosphamide Combination Therapy for Acute Phase Neuro-Behçet¡¯s Disease Ç¥Á¤À±(¼­¿ïÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 11:00~11:30 Immunoglobulin G4-Related Hypertrophic Pachymeningitis with an Isolated Scalp Mass Mimicking a Brain Tumor ÃÖÈ¿Áø(°¡ÃµÀÇ´ë)

±³À°½Ã°£ 06¿ù 01ÀÏ 4°­ÀÇ½Ç 11:30~12:00 Fatal Hemorrhagic Polymyositis Á¤Á¾Çõ(¿ø±¤ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2023³â Á¦7Â÷ ³»°úºÐ°úÀü¹®ÀÇ ¿¬¼ö±³À° : 2024-06-01""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³â ´ëÇѼÒÈ­±â³»½Ã°æÇÐȸ ÀüºÏÁöȸ Á¦12ȸ ¿¬¼ö°­Á : 2024-06-01
´ÙÀ½±Û Á¦516Â÷ ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ºÎ»ê¡¤¿ï»ê¡¤°æ³²Áöȸ Çмú´ëȸ : 2024-06-01
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21045 ¼­¿ï 2024³â Á¦23ȸ ´ëÇÑôÃ߽űâ¼úÇÐȸ Ãá°è Á¤±âÇмú´ëȸ : 2024-06-29 0 4 2024-06-18
21044 ¼­¿ï (¿Â¶óÀÎ)2024³â »ó¹Ý±â ÀÇ·áºÐÀï ¿¹¹æ ¿¬¼ö±³À° : 2024-06-29 0 5 2024-06-18
21043 ºÎ»ê 2024³â ºÎ¿ï°æ ½½°üÀý ¿¬±¸È¸ ÇÏ°è¿öÅ©¼¥ : 2024-06-29 0 8 2024-06-18
21042 ¼­¿ï ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦10Â÷ °æÁ÷Àü¹®±³À°°úÁ¤ : 2024-06-29 0 6 2024-06-18
21041 ¼­¿ï Çѱ¹¿©¼ºÁ¤½ÅÀÇÇÐȸ ³­¹Î/ÀÌÁֹΠÁ¤½Å°Ç°­ : 2024-06-29 0 5 2024-06-18
21040 °æ±â Á¦12ȸ ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø ½Å°æ¿Ü°ú ¿¬¼ö°­Á : 2024-06-29 0 2 2024-06-18
21039 ºÎ»ê 2024³â Á¦2ȸ ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Transitional Urology Symposium : 2024-06-29 0 10 2024-06-18
21038 ¼­¿ï 2024³â ´ëÇѳëÀνŰæÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 13 2024-06-18
21037 ¼­¿ï Á¦6ȸ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-06-29 0 11 2024-06-18
21036 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-29 0 7 2024-06-18
21035 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 3 2024-06-18
21034 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 2ÀÏÂ÷ : 2024-06-28 0 4 2024-06-18
21033 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦298Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-28 0 12 2024-06-18
21032 ¼­¿ï 2024 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 7 2024-06-18
21031 ¼­¿ï (2ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-28 0 3 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷